ALTERED CELL-MEDIATED-IMMUNITY TO GROUP-A HEMOLYTIC STREPTOCOCCAL ANTIGENS IN CHRONIC PLAQUE PSORIASIS

被引:38
作者
BAKER, BS
POWLES, AV
MALKANI, AK
LEWIS, H
VALDIMARSSON, H
FRY, L
机构
[1] ST MARYS HOSP & MED SCH,DEPT DERMATOL & IMMUNOL,LONDON W2,ENGLAND
[2] LANDSPITALINN,REYKJAVIK,ICELAND
基金
英国惠康基金;
关键词
D O I
10.1111/j.1365-2133.1991.tb06036.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The proliferative lymphocyte response to sonicated group A, beta-haemolytic streptococci (Strep-A) was measured by thymidine incorporation in 78 patients with psoriasis (guttate, chronic plaque or both). Lymphocytes from 72 of these patients were also cultured with streptokinase/streptodornase (SK/SD), and 20 of the patients with chronic plaque psoriasis were further tested with PPD, Candida albicans and sonicated Streptococcus mutans, a bacterial type not associated clinically with psoriasis. The median stimulation index (SI) of the psoriasis group to the Strep-A preparation was significantly higher than that of a group of 27 non-psoriatic individuals (P < 0.05). Within this group, only the patients with chronic plaque psoriasis (n = 42) showed a significantly increased proliferative response compared to the non-psoriatic controls (median SI = 123.8 and 31.9, respectively, P < 0.01). Although the lymphocyte response of the chronic plaque group to SK/SD was also markedly higher than that of the control group, this difference did not reach statistical significance. In addition, these patients did not show significantly increased responses to any of the other antigens tested, including S. mutans. No correlation was observed between the degree of proliferation to Strep-A and disease extent or activity. Similarly, ASO titres, which were raised in 11 out of 23 guttate and three out of nine chronic plaque psoriasis patients tested, did not correlate with the proliferative responses observed.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 13 条
[1]  
COHENTERVAERT WC, 1970, DERMATOLOGICA, V140, P282
[2]   LYMPHOCYTE-ACTIVATION BY STREPTOCOCCAL ANTIGENS IN PSORIASIS [J].
GROSS, WL ;
PACKHAUSER, U ;
HAHN, G ;
WESTPHAL, E ;
CHRISTOPHERS, E ;
SCHLAAK, M .
BRITISH JOURNAL OF DERMATOLOGY, 1977, 97 (05) :529-536
[3]  
HARO HS, 1954, ANN MED INTERN FENNI, V43, P216
[4]   RELATIONSHIP OF THE FINAL ALPHA-KERATIN COMPOSITIONS IN DYSKERATOSES TO THOSE ALONG THE NORMAL KERATINIZATION PATHWAY - ETIOLOGICAL AND DIAGNOSTIC-SIGNIFICANCE [J].
HUNTER, I ;
SKERROW, D .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 120 (03) :363-369
[5]   INFLAMMATORY AND IMMUNE CELL-FUNCTION IN PSORIASIS - SUBTLE DISORDER .1. INVIVO AND INVITRO SURVEY [J].
KRUEGER, GG ;
HILL, HR ;
JEDERBERG, WW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 71 (03) :189-194
[6]  
MCFADDEN JP, 1990, ACTA DERM-VENEREOL, V70, P262
[7]  
NORHOLM-PEDERSEN A, 1952, Acta Derm Venereol, V32, P159
[8]  
NORLIND R, 1955, ACTA RHEUMATOL SCAND, V1, P135
[9]   CELLULAR REACTIVITY STUDIES TO STREPTOCOCCAL ANTIGENS - MIGRATION-INHIBITION STUDIES IN PATIENTS WITH STREPTOCOCCAL INFECTIONS AND RHEUMATIC-FEVER [J].
READ, SE ;
FISCHETTI, VA ;
UTERMOHLEN, V ;
FALK, RE ;
ZABRISKIE, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (02) :439-450
[10]   USE OF RIFAMPIN WITH PENICILLIN AND ERYTHROMYCIN IN THE TREATMENT OF PSORIASIS - PRELIMINARY-REPORT [J].
ROSENBERG, EW ;
NOAH, PW ;
ZANOLLI, MD ;
SKINNER, RB ;
BOND, MJ ;
CRUTCHER, N .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (05) :761-764